Suchergebnisse - Portal für Medizinische Datenmodelle (MDM-Portal)

visit week 12 physical examination Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 03.11.17 - 1 Formular, 10 Itemgruppen, 16 Datenelemente, 1 Sprache

Itemgruppen: administrative data, vital signs, 12-lead ECG, central laboratory, clinical global impression questionnaire, unified parkinson's disease rating scale questionnaire, parkinson's disease sleep scale, Beck Depression Inventory, EPWORTH SLEEPINESS SCALE, STABLE UPDRS MOTOR SCORE

Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

CRF tracking/review form (TRF) Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 03.11.17 - 1 Formular, 4 Itemgruppen, 11 Datenelemente, 1 Sprache

Itemgruppen: administrative data, Screening failure, CRF tracking review form, Comments and signature

Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

Questionnaires Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 02.11.17 - 1 Formular, 2 Itemgruppen, 6 Datenelemente, 1 Sprache

Itemgruppen: administrative data, Questionnaires

Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

study conclusion Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 18.10.17 - 1 Formular, 5 Itemgruppen, 10 Datenelemente, 1 Sprache

Itemgruppen: administrative data, Study conclusion, Pregnancy information, Overall compliance, Investigator signature

Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

Serious adverse events Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 18.10.17 - 1 Formular, 14 Itemgruppen, 56 Datenelemente, 1 Sprache

Itemgruppen: administrative data, Serious adverse event, Serious adverse event, Seriousness, Demography data, Recurrence of SAE, Possible Causes of SAE Other Than Investigational Product, Relevant Medical Conditions, Other relevant risk factors, Relevant concomitant medications, Details of Investigational Product, Details of relevant Assessments, Narrative Remarks, Investigator information

Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

Non-serious adverse events Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 18.10.17 - 1 Formular, 3 Itemgruppen, 11 Datenelemente, 1 Sprache

Itemgruppen: administrative data, Non-serious adverse events, Non-serious adverse events

Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease

concomitant medication Ropinirole CR Ropinirole IR Monotherapy 101468/168

- 18.10.17 - 1 Formular, 3 Itemgruppen, 11 Datenelemente, 1 Sprache

Itemgruppen: administrative data, concomitant medication, concomitant medication

Study ID: 101468/168 Clinical Study ID: 101468/168 Study Title: A Randomised, Double Blind, Three Period, Cross-Over Study of Ropinirole CR and Ropinirole IR Monotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara Study Indication: Parkinson Disease